Avatrombopag in adults with immune thrombocytopenia: A multicentre real-life observational study in Madrid, Spain (AVAMAD study)

被引:0
|
作者
Pascual-Izquierdo, Cristina [1 ]
Llacer-Ferrandis, Ma. Jose [1 ]
de-la-Iglesia, Almudena [2 ]
Monsalvo-Saornil, Silvia [2 ]
Menor-Gomez, Maria [3 ]
Gil-Fernandez, Juan Jose [3 ]
Chica-Gullon, Esther [4 ]
alvarez-Roman, Maria Teresa [5 ]
Perez-Segura, Gloria [6 ]
Zafra, Denis [6 ]
Ortuzar-Pasalodos, Ariana [7 ]
Gonzalez-Gascon-y-Marin, Isabel Teresa [8 ]
Moreno, Gemma [9 ]
Arquero-Portero, Teresa [10 ]
Moreno-Carbonell, Marta [1 ]
Revilla, Nuria [10 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Inst Invest Gregorio Maranon, Hematol, Madrid, Spain
[2] Hosp Univ Puerta Hierro, Hematol, Madrid, Spain
[3] Hosp Univ Principe Asturias, Hematol, Madrid, Spain
[4] Hosp Univ Getafe, Madrid, Spain
[5] Hosp Univ La Paz, Hematol, Madrid, Spain
[6] Hosp Univ 12 Octubre, Hematol, Madrid, Spain
[7] Hosp Univ Rey Juan Carlos, Hematol, Madrid, Spain
[8] Hosp Univ Infanta Leonor, Hematol, Madrid, Spain
[9] Hosp Univ Ramon & Cajal, Hematol, Madrid, Spain
[10] Hosp Univ Fdn Jimenez Diaz, Inst Invest Fdn Jimenez Diaz IIS FJD, Hematol, Madrid, Spain
关键词
avatrombopag; immune thrombocytopenia; ITP; TPO-RA;
D O I
10.1111/bjh.19975
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Immune thrombocytopenia (ITP) is a rare acquired disorder where thrombopoietin-receptor agonists have become mainstays of ITP treatment. With the recent approval of avatrombopag (AVA), real-world studies are essential to evaluate its efficacy and safety. Our study of 66 adult ITP patients treated with AVA showed a high response rate. After starting AVA, 74.2% did not require rescue medications, with minimal adverse effects. Additionally, 56.0% of patients reduced other ITP medications, and all patients aged >= 65 years responded to AVA. Results should be confirmed in larger studies, but AVA appears to be an effective and safe treatment for ITP patients.
引用
收藏
页码:652 / 656
页数:5
相关论文
共 50 条
  • [1] Avatrombopag in Immune Thrombocytopenia (ITP). Real-Life Experience of Its Use in Hospitals within the Community of Madrid, Spain (AVAMAD STUDY)
    Ferrandis, Maria Jose Llacer
    Saornil, Silvia Monsalvo
    De laiglesia, Almudena
    Vazquez, Celia Martinez
    Gomez, Maria Menor
    Gullon, Esther Chica
    Segura, Gloria Perez
    Revilla, Nuria
    Arquero, Teresa
    Pasalodos, Ariana Ortuzar
    Roman, Maria Teresa Alvarez
    Gonzalez-Gascon, Isabel
    Jimenez, Gemma Moreno
    Izquierdo, Cristina Pascual
    BLOOD, 2023, 142
  • [2] Real-Life Management of Immune Thrombocytopenia in the Elderly: A Multicentre Study on 526 Patients
    Palandri, Francesca
    Santoro, Cristina
    Carpenedo, Monica
    Silvia, Cantoni
    Barcellini, Wilma
    Carli, Giuseppe
    Carrai, Valentina
    Rossi, Elena
    Rivolti, Elena
    Lucchesi, Alessandro
    Rotondo, Francesco
    Auteri, Giuseppe
    Ruggeri, Marco
    Fusco, Alessio
    Baldacci, Erminia
    Catani, Lucia
    Bartoletti, Daniela
    Cavo, Michele
    De Stefano, Valerio
    Mazzucconi, Maria Gabriella
    Rodeghiero, Francesco
    Vianelli, Nicola
    BLOOD, 2018, 132
  • [3] Severe Atopic Dermatitis In Spain: A Real-Life Observational Study
    Sicras-Mainar, Antoni
    Navarro-Artieda, Ruth
    Armario-Hita, Jose C.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2019, 15 : 1393 - 1401
  • [4] Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
    Al-Samkari, Hanny
    Jiang, Debbie
    Gernsheimer, Terry
    Liebman, Howard
    Lee, Susie
    Wojdyla, Matthew
    Vredenburg, Michael
    Cuker, Adam
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 (03) : 359 - 366
  • [5] Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
    Wang, Zhifa
    Zhang, Aijun
    Xu, Zhongjin
    Wang, Nan
    Zhang, Jialu
    Meng, Jinxi
    Dong, Shuyue
    Ma, Jingyao
    Hu, Yu
    Ouyang, Juntao
    Chen, Zhenping
    An, Qi
    Cheng, Xiaoling
    Wu, Runhui
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 1958 - 1965
  • [6] Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study
    Cattaneo, Chiara
    Busca, Alessandro
    Gramegna, Doriana
    Farina, Francesca
    Candoni, Anna
    Piedimonte, Monica
    Fracchiolla, Nicola
    Pagani, Chiara
    Del Principe, Maria Ilaria
    Tisi, Maria Chiara
    Offidani, Massimo
    Fanci, Rosa
    Ballanti, Stelvio
    Spolzino, Angelica
    Criscuolo, Marianna
    Marchesi, Francesco
    Nadali, Gianpaolo
    Delia, Mario
    Picardi, Marco
    Sciume, Margherita
    Mancini, Valentina
    Olivieri, Attilio
    Tumbarello, Mario
    Rossi, Giuseppe
    Pagano, Livio
    HEMASPHERE, 2019, 3 (06):
  • [7] PLATON: use of romiplostim to treat chronic primary immune thrombocytopenia An observational, nonintervention study of real-life practice
    Mihaylov, Georgi
    Skopec, Barbara
    Sninska, Zuzana
    Tzvetkov, Nikolai
    Cerna, Olga
    Ivanushkin, Vladlen
    Niepel, Daniela
    Bjorklof, Katja
    Cernelc, Peter
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (02) : 227 - 234
  • [8] Long-Term Eltrombopag in Children with Chronic Immune Thrombocytopenia: A SingleCenter Extended Real-Life Observational Study in China
    Wang, Zhifa
    Wang, Nan
    Ouyang, Juntao
    Ma, Jingyao
    Poon, Man-Chiu
    Chen, Zhenping
    Cheng, Xiaoling
    Wu, Runhui
    BLOOD, 2023, 142
  • [9] Avatrombopag treatment response in patients with immune thrombocytopenia: the REAL-AVA 1.0 study
    Oladapo, Abiola
    Kolodny, Scott
    Vredenburg, Michael
    Swallow, Elyse
    Goldschmidt, Debbie
    Sarathy, Kirthana
    Lopez, Priscilla
    Maitland, Hillary
    Yee, John
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [10] Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI)
    Pascual-Izquierdo, Cristina
    Sanchez-Gonzalez, Blanca
    Canaro-Hirnyk, Mariana-Isabel
    Garcia-Donas, Gloria
    Menor-Gomez, Maria
    Gil-Fernandez, Juan-Jose
    Monsalvo-Saornil, Silvia
    de-Laiglesia, Almudena
    Alvarez-Roman, Maria-Teresa
    Jarque-Ramos, Isidro
    Llacer, Maria-Jose
    Pedrote-Amador, Begona
    Zafra-Torres, Denis
    Caparros-Miranda, Isabel
    Ortuzar-Pasalodos, Ariana
    Revilla-Calvo, Nuria
    Bastida-Bermejo, Jose-Maria
    Chica-Gullon, Esther
    Alvarellos, Montserrat
    Jimenez-Barcenas, Reyes
    Bernat, Silvia
    Martinez-Carballeira, Daniel
    Lakhwani, Sunil
    Lopez-Ansoar, Elsa
    Moreno-Beltran, Maria-Esperanza
    Lorenzo-Vizcaya, Alvaro
    Aguirre, Maria-Aranzazu
    Lasa-Eguialde, Maialen
    Canet, Marta
    Gonzalez-Gascon-y-Marin, Isabel-Teresa
    Caballero-Navarro, Gonzalo
    Cuesta, Amalia
    Diaz-Lopez, Marta
    Arquero, Teresa
    Moreno-Carbonell, Marta
    Mingot-Castellano, Maria-Eva
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (12) : 2328 - 2339